Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation

SIMPLE SUMMARY: KRAS G12C mutations are important oncogenic mutations in lung cancer that can now be targeted by allosteric small molecule inhibitors. We assessed the imaging features and patterns of metastases in these lung cancers compared to other mutated lung cancers. We found that KRAS G12C NSC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Wu, Markus Y., Zhang, Eric W., Strickland, Matthew R., Mendoza, Dexter P., Lipkin, Lev, Lennerz, Jochen K., Gainor, Justin F., Heist, Rebecca S., Digumarthy, Subba R.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8304953/
https://ncbi.nlm.nih.gov/pubmed/34298783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143572
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items